A love of music and the enduring compassion of a childhood friend are helping a 25-year-old Michigan woman weather the rigors of multiple sclerosis.
Tenacious by nature, Paul White confronts multiple sclerosis, chronic pain and homelessness as he fights to get back on his feet.
Phil Simon had reached the end of the line with existing multiple sclerosis medications. A year after starting a new drug, his walking and stamina have improved.
The new treatment, Mavenclad, is recommended for patients who have seen less success with other MS medications.
Scientists seek to unravel how viruses trigger disease.
Lower levels of vitamin D have been associated with a rise in risk for multiple sclerosis.
At a critical point in the progression of his multiple sclerosis, a local chef pins his hopes on a breakthrough medication.
Saturated fats from certain foods can cause inflammation that leads to a relapse of MS in younger patients, new research shows.
Scans revealed less brain shrinkage in exercise group.
Researcher calls the benefits of ocrelizumab 'quite stunning.'
Exposure to ultra-low temperatures shows no benefits and may be dangerous.
Prescription doses can treat chronic pain, muscle spasms and nausea—but there are still downsides to the drug.